FDA Inspection
Mylan Laboratories LimitedMylan Laboratories Limited – FDA Inspection, Apr 18, 2017
Record Details
This FDA Inspection record concerns Mylan Laboratories Limited, with an inspection on April 18, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 99533dcc-83c1-4d95-8f05-d1a6aea3fe37
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1017161
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mylan Laboratories Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| July 10, 2026 | Not classified | Office of Inspections and Investigations | |
| February 24, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 16, 2023 | Not classified | Office of Inspections and Investigations | |
| February 28, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 13, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mylan Laboratories Limited
- FDA Inspection 1329374 - 2026-07-10
- FDA Inspection 1204816 - 2023-02-24
- FDA Inspection 1196646 - 2023-01-16
- FDA Inspection 1119165 - 2020-02-28
- FDA Inspection 1089838 - 2019-05-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.